Investing for Life


Book Description




Investing for life


Book Description




A Companion to Bioethics


Book Description

This second edition of A Companion to Bioethics, fully revised and updated to reflect the current issues and developments in the field, covers all the material that the reader needs to thoroughly grasp the ideas and debates involved in bioethics. Thematically organized around an unparalleled range of issues, including discussion of the moral status of embryos and fetuses, new genetics, life and death, resource allocation, organ donations, AIDS, human and animal experimentation, health care, and teaching Now includes new essays on currently controversial topics such as cloning and genetic enhancement Topics are clearly and compellingly presented by internationally renowned bioethicists A detailed index allows the reader to find terms and topics not listed in the titles of the essays themselves




Global Health and International Community


Book Description

This book is available as open access through the Bloomsbury Open Access programme and is available on www.bloomsburycollections.com. Global health arguably represents the most pressing issues facing humanity. Trends in international migration and transnational commerce render state boundaries increasingly porous. Human activity in one part of the world can lead to health impacts elsewhere. Animals, viruses and bacteria as well as pandemics and environmental disasters do not recognize or respect political borders. It is now widely accepted that a global perspective on the understanding of threats to health and how to respond to them is required, but there are many practical problems in establishing such an approach. This book offers a foundational study of these urgent and challenging problems, combining critical analysis with practically focused policy contributions. The contributors span the fields of ethics, human rights, international relations, law, philosophy and global politics. They address normative questions relating to justice, equity and inequality and practical questions regarding multi-organizational cooperation, global governance and international relations. Moving from the theoretical to the practical, Global Health and International Community is an essential resource for scholars, students, activists and policy makers across the globe.




Big Business, Poor Peoples


Book Description

Transnational corporations are one of the most important actors in the global economy, occupying a more powerful position than ever before. In their persistent battle to increase profits, they have increasingly turned to the developing world, a world that holds many attractions for them. But what is their impact on the poor? Now in its second edition, Big Business, Poor Peoples finds that these corporations are damaging the lives of millions of poor people in developing countries. Looking at every sector where transnational corporations are involved, this vital book is packed with detail on how the poor are affected. The book exposes how developing countries’ natural resources are being ceded to TNCs and how governments are unwilling or unable to control them. The author argues that TNCs, answerable to no one but their shareholders, have used their money, size and power to influence international negotiations and taken full advantage of the move towards privatization to influence government policies; sovereignty is passing into corporate hands, and the poor are paying the price. But people are fighting back: citizens, workers, and communities are exposing the corporations and looking for alternatives. The first edition of this path-breaking book put the issue of transnational corporations and the poor firmly on the agenda. This second edition contains significant new and updated material and is an essential read for anyone who wants to know more about the effects of corporate power on the poor.







Any of Our Business?


Book Description

Any of our Business? : Human rights and the UK private sector, first report of session 2009-10, Vol. 2: Oral and written Evidence




Post-Trial Access to Drugs in Developing Nations


Book Description

This book begins the discourse on post-trial access to drugs in developing countries. Underlying ethical issues in global health inequalities and global health research serve as the context of the debate. Due to rampant allegations of violations of rights of research participants, especially in developing countries, it discusses the regulatory infrastructure and ethical oversight of international clinical research, thus emphasizing the priority of safeguarding the rights of research participants and host populations as desiderata in conducting clinical trials in developing countries. This is the first book that analyzes the major obstacles of affordable access to drugs in developing countries – patent and non-patent factors and how they can be overcome through a middle ground approach and a new paradigm to establish global health justice which includes national and global health responsibilities. The book also deals extensively with all complex aspects of the discourse on affordable access to drugs in developing countries, including intellectual property law, international regulations, political and cultural systems, international trade agreements. Furthermore it contains a robust ethical debate and in-depth analysis. The book crafts a paradigm of global health justice involving a sliding scale of national and global responsibilities for the realization of the right to health in general and access to drugs in particular.




Incentives for Global Public Health


Book Description

This portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis, the SARS virus, influenza, and diseases of poverty. The essays explore the diplomatic negotiations and disputes in key international fora, such as the World Trade Organization, the World Health Organization and the World Intellectual Property Organization. Drawing upon international trade law, innovation policy, intellectual property law, health law, human rights and philosophy, the authors seek to canvass policy solutions which encourage and reward worthwhile pharmaceutical innovation while ensuring affordable access to advanced medicines. A number of creative policy options are critically assessed, including the development of a Health Impact Fund, prizes for medical innovation, the use of patent pools, open-source drug development and forms of 'creative capitalism'.